Genetic alterations in normal epithelium of colorectal cancer patients may be a useful indicator for subsequent metachronous tumor development

Annals of Surgical Oncology

Volumn 9, Issue 6, 2002, Pages 580-586

  Koshiji, Minori ^a   Yonekura, Yasuhiro ^a   Saito, Takamichi ^a   Sakaida, Noriko ^a   Uemura, Yoshiko ^a   Yoshioka, Kazuhiko ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Loss of heterozygosity; Malignant potential; Microsatellite analysis; Prospective observation study

Indexed keywords

GENOMIC DNA; PROTEIN P53; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INVASION; CANCER TISSUE; CLINICAL FEATURE; COLON MUCOSA; COLORECTAL CANCER; CORRELATION ANALYSIS; GENE MUTATION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; PREOPERATIVE PERIOD; TUMOR VOLUME;

COLORECTAL NEOPLASMS; FEMALE; HUMANS; JAPAN; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL;

EID: 0036064596     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/aso.2002.9.6.580     Document Type: Article

References (27)

1. Molecular markers of prognosis in colorectal cancer
2. A comparative microsatellite analysis of colorectal cancer in patients <35 years and >50 years of age
3. Genetic pathways in the evolution of morphologically distinct colorectal neoplasm
4. Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis
5. Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma
6. Identification of a region of frequent loss of heterozygosity at 11q24 in colorectal cancer
7. Prospective assessment of allelic losses at 4p14-16 in colorectal cancer: Two mutational patterns and a locus associated with poorer survival
8. Genetic alterations during colorectal-tumor development
9. Colorectal cancer: Future population screening for early colorectal cancer
10. Contributions of molecular genetics to the clinical management of colorectal cancer
11. Fine mapping of colon tumor susceptibility (Scc) genes in the mouse, different from genes known to be somatically mutated in colon cancer
12. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination
13. Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer
14. Combined analysis of microsatellite instability and K-ras mutation increases detection incidence of normal samples from colorectal cancer patients
15. Genome-wide allelotyping indicates increased loss of heterozygosity on 9p and 14q in early age of onset colorectal cancer
16. Genomic instability in colorectal carcinomas: Comparison of different evaluation methods and their biological significance
17. Microsatellite instability in young patients with colorectal cancer
18. Genetic analysis of a breast-ovarian cancer family, with 7 cases of colorectal cancer linked to BRCA1, fails to support a role for BRCA1 in colorectal tumorigenesis
19. Molecular predictors of survival after adjuvant chemotherapy for colon cancer
20. Allelic imbalance and microsatellite instability of the DCC gene in colorectal cancer in patients under the age of 35 using fluorescent DNA technology
21. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC
22. High and low annealing temperatures increase both specificity and yield in touchdown and stepdown PCR
23. Loss of heterozygosity assay for molecular detection of cancer using energy transfer primers and capillary array electrophoresis
24. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma
25. Semiautomated quantitative detection of loss of heterozygosity in the tumor suppressor gene p53
26. Malignant fibrous histiocytoma: Inherited and sporadic forms have loss of heterozygosity at chromosome bands 9p21-22-evidence for a common genetic defect
27. Persistence of genetically altered fields in head and neck cancer patients: Biological and clinical implications